VIP

Vasoactive intestinal peptide; GPCR ligand studied in circadian, immune, and pulmonary models.

Also known as

Vasoactive intestinal peptide · VIP neurotransmitter/hormone

Overview

VIP is vasoactive intestinal peptide, a GPCR ligand studied in circadian, immune, and pulmonary research models. Literature covers smooth-muscle, inflammatory, and SCN-related signaling endpoints.

It is a neuropeptide/hormone research tool spanning gut–brain and airway biology. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• VPAC receptor signaling endpoints

• - Circadian and SCN-related research markers

• - Pulmonary and airway inflammation readouts where studied

• - Immune-modulation measures in VIP literature

• - Gut–brain peptide pharmacology co-markers

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early cofactor and metabolic-shuttle readouts; exposure establishing.

• - Week 3–4: Clearer lipid-handling and energy markers in short research windows.

• - Month 2–3: More stable wellness and metabolic endpoints in extended designs.

• - Month 3–6: Sustained lipotropic and energy-related observations where studied longer.

Footer RUO

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.